- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06318663
Survivor Mom Companion Comparison Study (SMC)
March 18, 2024 updated by: Ogechi Christine Kalu, State University of New York at Buffalo
Survivor Moms' Companion: A Perinatal PTSD Program
The overall goal of the SMC is to help reduce posttraumatic stress symptomology for pregnant persons with a history of trauma.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The study is a pilot randomized waitlist-controlled trial that examines the preliminary efficacy of the SMC for reducing PTSD symptomology as compared to a waitlist control group.
Also, it aims to assess the feasibility and acceptability of the SMC.
It examines how changes in the theorized mechanisms (emotion regulation, interpersonal sensitivity) mediate the relationship between the intervention and PTSD symptomology.
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mickey Sperlich, PhD
- Phone Number: (716)-645-9087
- Email: msperlic@buffalo.edu
Study Locations
-
-
New York
-
Buffalo, New York, United States, 14203
- Recruiting
- Buffalo Prenatal-Perinatal Network
-
Contact:
- LuAnne Brown
- Email: lb@bppn.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- English- or Spanish-speaking
- Currently pregnant or in the postpartum period
- Age 18 and older
- A history of trauma and PTSD
- Able to comprehend the study protocol and consent form and provide verbal consent and
- able to commit to a minimum of 4 weekly intervention sessions.
Exclusion Criteria:
- Non-English or non-Spanish-speaking,
- less than 18 years of age,
- those with psychotic conditions or developmental disabilities requiring guardianship,
- those with high-risk pregnancies necessitating extended bedrest or inpatient care, and
- those unable to commit to completing the intervention sessions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Survivor Mom Companion Program
Participants in the Survivor Moms' Companion intervention will complete a minimum of 4 Survivor Moms' Companion psychoeducational modules with weekly tutor support and will then complete an ending assessment.
Sessions with tutors are conducted over the phone or in person at the Buffalo Prenatal and Perinatal Network and last for 45 minutes.
|
Weekly intervention sessions will follow the survivor Moms' Companion manualized modules.
One module each week.
The module centers on reinforcement of information introduced in each previous module, then emotional support, and referrals to additional services or specialists as needed.
Participants in each session will practice applying knowledge and skills using the module's vignettes.
Process guides prompt inquiry about in vivo management of post-traumatic stress disorder reactions and emotional and interpersonal responses to events since the last session.
Each module may require 45 minutes of self-study before each session and 45 minutes of in-session time spent with the interventionist.
|
Placebo Comparator: Waitlist Control
Participants in the waitlist control group will complete the baseline assessment over the phone, wait six weeks, and then complete the ending assessment.
Those on the waitlist will then be offered the Survivor Moms' Companion intervention.
Sessions with tutors are conducted over the phone or in person at the Buffalo Prenatal and Perinatal Network and last for 45 minutes.
|
Weekly intervention sessions will follow the survivor Moms' Companion manualized modules.
One module each week.
The module centers on reinforcement of information introduced in each previous module, then emotional support, and referrals to additional services or specialists as needed.
Participants in each session will practice applying knowledge and skills using the module's vignettes.
Process guides prompt inquiry about in vivo management of post-traumatic stress disorder reactions and emotional and interpersonal responses to events since the last session.
Each module may require 45 minutes of self-study before each session and 45 minutes of in-session time spent with the interventionist.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Childhood Trauma Questionnaire
Time Frame: This will be administered prior to the intervention as part of the starting assessment.
|
For eligibility screening we will use the 5 sentinel items from the Childhood Trauma Questionnaire.
The higher the score is, the greater the severity of abuse for that scale.
There are four categories of severity for each trauma type: None (minimal); Low (to Moderate); Moderate (to Severe); and Severe (to Extreme).
|
This will be administered prior to the intervention as part of the starting assessment.
|
Primary Care Post Traumatic Stress Disorder Screen for Diagnostic and Statistical Manual of Mental Disorders-5
Time Frame: This will be administered at the prior to the intervention as part of the starting assessment.
|
The Primary Care post-traumatic stress Screen for Diagnostic and Statistical Manual of Mental Disorders is a 5-item screen designed to identify individuals with probable post-traumatic stress disorder.
Primary Care Post Traumatic Stress Disorder considered "positive" if the respondent answers "yes" to any 3 items in the questions listed in the scale.
|
This will be administered at the prior to the intervention as part of the starting assessment.
|
Adverse Childhood Experiences Questionnaire
Time Frame: This will be administered prior to the intervention as part of the starting assessment.
|
Scale to assess the presence of childhood trauma.
If the Adverse childhood experience score is 1-3 without Adverse Childhood Experience, the responder is at "intermediate risk" for toxic stress.
If the Adverse childhood experience score is 1-3 and there is the likelihood of at least one Adverse childhood experience-associated condition, or if the Adverse childhood experiences score is 4 or higher, the responder is at "high risk" for toxic stress.
|
This will be administered prior to the intervention as part of the starting assessment.
|
Post Traumatic Stress Disorder Checklist for Diagnostic and Statistical Manual of Mental Disorders
Time Frame: This will be administered prior to the intervention as part of the starting assessment and repeated after the intervention to assess any changes.
|
Scale to assess presence of post-traumatic stress symptoms.
Severity can be determined adding scores of each item together to determine a total score.
A total score of 33 or higher may indicate severe post-traumatic stress disorder.
|
This will be administered prior to the intervention as part of the starting assessment and repeated after the intervention to assess any changes.
|
Dissociative Subtype of Post Traumatic Stress Scale
Time Frame: This will be administered prior to the intervention as part of the starting assessment and repeated after the intervention to assess any changes.
|
Scale to assess dissociative symptoms.
Each item on the measure is rated on a 5-point scale (0=Not at all; 1=Once or twice; 2=Almost every day; 3=About once a day, and 4=More than once a day).
The total score can range from 0 to 32, with higher scores indicating greater severity of dissociative experiences.
|
This will be administered prior to the intervention as part of the starting assessment and repeated after the intervention to assess any changes.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Health Questionnaire-9
Time Frame: This will be administered prior to the intervention as part of the starting assessment and repeated after the intervention to assess any changes.
|
A multipurpose instrument for screening and measuring severity of depression.
In the scale 1-4 = minimal depression, 5-9 = mild depression, 10-14 = moderate depression, 15-19 = moderately severe depression and 20-27= severe depression.
Thus, the higher the total score the higher the perceived level of depression.
|
This will be administered prior to the intervention as part of the starting assessment and repeated after the intervention to assess any changes.
|
State Trait Anger Expression Inventory
Time Frame: This will be administered prior to the intervention as part of the starting assessment and repeated after the intervention to assess any changes.
|
A psychometric assessment that measures the experience and control of anger.
scores are classified as "no or low anxiety" (20-37), "moderate anxiety" (38-44), and "high anxiety" (45-80).
A higher score signifies higher anxiety.
|
This will be administered prior to the intervention as part of the starting assessment and repeated after the intervention to assess any changes.
|
Symptoms Checklist-90 Revised/Interpersonal Sensitivity Subscale
Time Frame: This will be administered prior to the intervention as part of the starting assessment and repeated after the intervention to assess any changes.
|
Instrument help evaluate a broad range of psychological problem symptoms.
Using a five-point scale ranging from "not at all" to "extremely", each item assesses the severity of distress the respondent experienced in the last 7 days.
Each item is graded from 1 to 5 according to the severity (none, mild, moderate, severe and extreme).
The scores of the items were regarded as extreme when the total is between 30-36.
|
This will be administered prior to the intervention as part of the starting assessment and repeated after the intervention to assess any changes.
|
Difficulties in Emotion Regulation Scale Short Form
Time Frame: This will be administered prior to the intervention as part of the starting assessment and repeated after the intervention to assess any changes.
|
Covers four dimensions of emotional regulation; awareness and understanding of emotions, acceptance of emotions and the ability to engage in goal-directed behavior.
All subscales are scored so that higher values reflect greater difficulty with emotion regulation.
|
This will be administered prior to the intervention as part of the starting assessment and repeated after the intervention to assess any changes.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Mickey Sperlich, PhD, State University of New York at Buffalo
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.
- Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, Stokes J, Handelsman L, Medrano M, Desmond D, Zule W. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl. 2003 Feb;27(2):169-90. doi: 10.1016/s0145-2134(02)00541-0.
- Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL. The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and Initial Psychometric Evaluation. J Trauma Stress. 2015 Dec;28(6):489-98. doi: 10.1002/jts.22059. Epub 2015 Nov 25.
- Kelly PJ, Kyngdon F, Ingram I, Deane FP, Baker AL, Osborne BA. The Client Satisfaction Questionnaire-8: Psychometric properties in a cross-sectional survey of people attending residential substance abuse treatment. Drug Alcohol Rev. 2018 Jan;37(1):79-86. doi: 10.1111/dar.12522. Epub 2017 May 7.
- Wolf EJ, Mitchell KS, Sadeh N, Hein C, Fuhrman I, Pietrzak RH, Miller MW. The Dissociative Subtype of PTSD Scale: Initial Evaluation in a National Sample of Trauma-Exposed Veterans. Assessment. 2017 Jun;24(4):503-516. doi: 10.1177/1073191115615212. Epub 2015 Nov 23.
- Prins A, Bovin MJ, Smolenski DJ, Marx BP, Kimerling R, Jenkins-Guarnieri MA, Kaloupek DG, Schnurr PP, Kaiser AP, Leyva YE, Tiet QQ. The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5): Development and Evaluation Within a Veteran Primary Care Sample. J Gen Intern Med. 2016 Oct;31(10):1206-11. doi: 10.1007/s11606-016-3703-5. Epub 2016 May 11.
- Spielberger CD. Professional manual for the State-Trait Anger Expression Inventory-2 (STAXI-2). Odessa,FL: Psychological Assessment Resources; 1999.
- Derogatis LR, Lipman RS, Covi L. SCL-90. Administration, scoring and procedures manual-I for the R (revised) version and other instruments of the Psychopathology Rating Scales Series. Chicago: Johns Hopkins University School of Medicine; 1977.
- Kaufman EA, Xia M, Fosco G, Yaptangco M, Skidmore CR, Crowell SE. The Difficulties in Emotion Regulation Scale Short Form (DERS-SF): Validation and replication in adolescent and adult samples. Journal of Psychopathology and Behavioral Assessment. 2016 Sep;38(3):443-55. doi: 10.1007/s10862-015-9529-3
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 12, 2023
Primary Completion (Estimated)
December 12, 2024
Study Completion (Estimated)
December 12, 2024
Study Registration Dates
First Submitted
March 11, 2024
First Submitted That Met QC Criteria
March 15, 2024
First Posted (Actual)
March 19, 2024
Study Record Updates
Last Update Posted (Actual)
March 20, 2024
Last Update Submitted That Met QC Criteria
March 18, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- STUDY00007685
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Posttraumatic Stress Symptom
-
Army Medical University, ChinaCompletedPosttraumatic Stress SymptomChina
-
Michigan State UniversityNot yet recruitingDepression | Intimate Partner Violence | Posttraumatic Stress Symptom
-
University of WyomingRecruitingTrauma | Posttraumatic Stress Disorder | Autism | Posttraumatic Stress SymptomUnited States
-
Region StockholmNot yet recruitingAnxiety | Depressive Symptoms | Physical Disability | Post-Intensive Care Syndrome | Posttraumatic Stress Symptom
-
Uppsala UniversityCompletedPosttraumatic StressSweden
-
Peking UniversityCompletedPosttraumatic Stress SymptomsChina
-
University Hospital, ToursCompletedPostTraumatic Stress DisorderFrance
-
University of Missouri, Kansas CityUniversity of KansasUnknownPosttraumatic Stress DisordersUnited States
-
Hadassah Medical OrganizationUnknownPosttraumatic Stress DisordersIsrael
-
Kent State UniversityAkron Children's Hospital; Ohio Board of RegentsCompletedPosttraumatic Stress Disorders
Clinical Trials on Survivor Mom Companion
-
Dana-Farber Cancer InstituteChildren's Cancer Research FundCompleted
-
Rush University Medical CenterNational Institute on Minority Health and Health Disparities (NIMHD); Ohio...RecruitingPreterm Birth | Infant, Very Low Birth Weight | Milk, Human | Pumping, BreastUnited States
-
George Washington UniversityCompleted
-
University of CoimbraFundação para a Ciência e a TecnologiaRecruitingPostpartum DepressionPortugal
-
Tulane UniversityNational Institute of Mental Health (NIMH)Active, not recruiting
-
Bar-Ilan University, IsraelRecruitingInfant Behavior | Breastfeeding | Mother-Infant Interaction | Smartphone AddictionIsrael
-
Washington University School of MedicineCompletedBreast CancerUnited States
-
Institut de Recherche pour le DeveloppementMedical Research Council; Institut Pasteur; Centre Muraz; REVS PLUS Burkina Faso; Young Gambian Mums Fund and other collaboratorsNot yet recruiting
-
Northeastern UniversityActive, not recruitingPhysical Activity | ExerciseUnited States
-
Massachusetts General HospitalPfizer; American Cancer Society, Inc.RecruitingBreast Cancer | Breast Neoplasms | Breast Carcinoma | Breast Cancer FemaleUnited States